glp-1 prescriptions growth slowing 2024 Are Up, Health Services Utilization Down, and GLP-1s Are a Major Driver: IQVIA's Update GLP-1 Receptor Agonist Market Size
Description
3
This discovery has led to multiple studies exploring whether these drugs could help treat not just food-related compulsions, but a broad spectrum of addictive behaviors
Trulicity (dulaglutide): A new GLP-1 receptor agonist once-weekly subcutaneous injection approved for the treatment of patients with Type 2 diabetes
It's usually temporary, and it's a sign that your body is making significant changes
